Wilbert Zwart finished his PhD training (Cum Laude) in 2009, trained at the Netherlands Cancer Institute (NKI), Amsterdam. Thereafter, he moved to the Cancer Research UK Cambridge Institute (lab of Jason Carroll), for a postdoc. In 2011, he started my independent research lab at the NKI as junior group leader (assistant professor), was promoted to group leader (professor level) in 2016 and senior group leader (full professor) in 2018. Since starting his lab, he received multiple prizes and awards including a  ‘Alpe d’HuZes Bas Mulder Award’, a ‘Pezcoller Fellowship’, an Dutch Scientific Organization NWO VIDI grant, and his work was recognized with the ‘Best Paper of the year Award’ by the Dutch Endocrine Society for multiple times. In 2017, he was co-appointed by Oncode Institute; a new nation-wide virtual institute focused on fundamental research in Oncology, where he leads the Research Theme on Personalized Therapy.  In 2018, I was appointed as professor of Functional Genomics in Oncology at the Eindhoven University of Technology, aimed to accelerate technological developments and discoveries in translational cancer research. He serves as Chair for the NKI Translational Research Board, which has the mission to facilitate full synergy between lab and clinic, and was co-appointed as Research Themeleader Precision Oncology of the NKI, responsible to maximize translational potential and advance precision oncology research within the institute.

His lab is focused on translational endocrinology and all his projects revolve around steroid hormone receptors. The mission of the lab is the identification of therapeutic targets, development of novel therapeutic agents and the discovery of new biomarkers, with the aim of personalized treatment of breast cancer and prostate cancer.